CME Group (NASDAQ:CME) Price Target Increased to $226.00 by Analysts at Keefe, Bruyette & Woods

CME Group (NASDAQ:CMEGet Free Report) had its price target increased by analysts at Keefe, Bruyette & Woods from $222.00 to $226.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “market perform” rating on the financial services provider’s stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 5.36% from the company’s current price.

CME has been the subject of a number of other reports. Barclays upped their price objective on shares of CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a report on Monday, April 8th. Argus lifted their price target on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. The Goldman Sachs Group downgraded shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a report on Wednesday, January 3rd. Morgan Stanley boosted their target price on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $210.00 price target (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus target price of $216.10.

View Our Latest Research Report on CME

CME Group Price Performance

Shares of CME traded up $1.91 on Thursday, reaching $214.50. The stock had a trading volume of 363,909 shares, compared to its average volume of 1,771,397. The firm has a 50-day moving average of $214.73 and a 200 day moving average of $211.93. The firm has a market capitalization of $77.22 billion, a PE ratio of 24.33, a PEG ratio of 6.09 and a beta of 0.49. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a twelve month low of $175.73 and a twelve month high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period in the previous year, the company earned $2.42 earnings per share. CME Group’s quarterly revenue was up 3.2% on a year-over-year basis. Sell-side analysts expect that CME Group will post 9.58 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of CME. OFI Invest Asset Management purchased a new position in CME Group in the third quarter valued at about $25,000. Gold Investment Management Ltd. acquired a new position in shares of CME Group in the 4th quarter worth $26,000. Northwest Financial Advisors purchased a new position in shares of CME Group during the fourth quarter valued at $28,000. Harbor Investment Advisory LLC boosted its position in CME Group by 966.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 145 shares during the last quarter. Finally, Compagnie Lombard Odier SCmA acquired a new stake in shares of CME Group in the third quarter worth about $37,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.